BioSpace News Archive

The Oncology Nursing Foundation has committed $420,000 over the next two years to support three major research grants that will be led by oncology nurse scientists.

South Carolina-based Hoowaki LLC has developed an innovative one-piece injection molded design for a COVID-19 swab to help close the gap in U.S. and global COVID-19 testing supplies.

AVEO Oncology (NASDAQ: AVEO) today announced that the U.S. Food and Drug Administration (FDA) accepted for filing its New Drug Application (NDA) seeking approval for tivozanib, the Company’s next-generation vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI), as a treatment for relapsed or refractory renal cell carcinoma (RCC).

Protecting treatment access for Canadian lung disease patients a top concern

Scott J. Knoer, MS, PharmD, FASHP, was sworn in as the 13th Chief Executive Officer and Executive Vice President of the American Pharmacists Association, during a virtual ceremony witnessed by APhA members and staff.

As the number of patients who require care for COVID-19 across the state of Michigan decreases and restrictions put in place by the Governor are lifted, Karmanos Cancer Institute continues to offer all cancer care services.

Berkshire Sterile Manufacturing located in Lee, MA has secured $16.5 million in financing from Berkshire Bank and Lee Bank to expand its operations in Lee.

People with diabetes are three times as likely to need hospitalization if infected with COVID-19

Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, reported completion of enrollment and randomization in its EMERGE pivotal Phase 3 efficacy trial of STS101 nasal powder) for the acute treatment of migraine.

G1 Therapeutics, Inc., a clinical-stage oncology company, announced that the company has entered into a debt financing agreement with Hercules Capital, Inc. for up to $100 million.